更正：美国医学毒理学学会和美国临床毒理学学会立场声明：纳美芬目前不应取代纳洛酮作为阿片类药物的主要解毒剂。

IF 2.5 4区医学 Q3 TOXICOLOGY

Journal of Medical Toxicology Pub Date : 2024-01-01 DOI:10.1007/s13181-023-00987-7

Andrew I Stolbach, Maryann Mazer-Amirshahi, Lewis S Nelson, Jon B Cole

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: American College of Medical Toxicology and the American Academy of Clinical Toxicology Position Statement: Nalmefene Should Not Replace Naloxone as the Primary Opioid Antidote at This Time.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Medical Toxicology TOXICOLOGY-

CiteScore

5.40

自引率

10.30%

发文量

期刊介绍： Journal of Medical Toxicology (JMT) is a peer-reviewed medical journal dedicated to advances in clinical toxicology, focusing on the diagnosis, management, and prevention of poisoning and other adverse health effects resulting from medications, chemicals, occupational and environmental substances, and biological hazards. As the official journal of the American College of Medical Toxicology (ACMT), JMT is managed by an editorial board of clinicians as well as scientists and thus publishes research that is relevant to medical toxicologists, emergency physicians, critical care specialists, pediatricians, pre-hospital providers, occupational physicians, substance abuse experts, veterinary toxicologists, and policy makers. JMT articles generate considerable interest in the lay media, with 2016 JMT articles cited by various social media sites, the Boston Globe, and the Washington Post among others. For questions or comments about the journal, please contact jmtinfo@acmt.net. For questions or comments about the journal, please contact jmtinfo@acmt.net.